ArticleNeoplasia (New York, N.Y.)2010

An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis.

Marion Zillhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.